ScholarIQanswers from OpenAlex & ORCID
Sandip Ganguly
ResearcherPublications, citations & collaboration network
Sandip Ganguly is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sandip Ganguly have?
ScholarIQindexed works
Sandip Ganguly has 108 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sandip Ganguly have?
ScholarIQcitation count
Sandip Ganguly has 1,195 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sandip Ganguly?
ScholarIQh-index
Sandip Ganguly has an h-index of 13 in OpenAlex.
What is the i10-index of Sandip Ganguly?
ScholarIQi10-index
Sandip Ganguly has an i10-index of 16 in OpenAlex.
What is the ORCID of Sandip Ganguly?
ScholarIQorcid
The ORCID for Sandip Ganguly is on the source record.
What is the OpenAlex record for Sandip Ganguly?
ScholarIQopenalex
The OpenAlex for Sandip Ganguly is on the source record.
What are the most-cited papers on Sandip Ganguly?
ScholarIQmost cited works
Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study
Antonio Passaro, Jing Wang, Yan Wang, S.-H. Lee, Barbara Melosky, Jin‐Yuan Shih, Jing Wang, K. Azuma, Óscar Juan, Manuel Cobo, Enriqueta Felip, Nicolas Girard, Alexis B. Cortot, Raffaele Califano, Federico Cappuzzo, Scott Owen, Sanjay Popat, Ju Le Tan, Jorge Salinas, Pascale Tomasini, Ryan D. Gentzler, William N. William, Karen L. Reckamp, Toshiaki Takahashi, Sandip Ganguly, Dariusz M. Kowalski, Alessandra Bearz, Melanie Mackean, P. Barala, Ariel B. Bourla, Angela Girvin, James Greger, Dawn Millington, Monica Withelder, John Xie, Tao Sun, Shalin Shah, B. Diorio, Roland E. Knoblauch, Joshua Bauml, Rosario García Campelo, Byoung Chul Cho
Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study
Bruno Sangro, Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri, Shukui Qin, Zhenggang Ren, Stephen L. Chan, Yasuaki Arai, Jeong Heo, Anh Mai, Jose Escobar, Yamil Alonso Lopez Chuken, Jung-Hwan Yoon, Won Young Tak, Valeriy V Breder, Tanita Suttichaimongkol, Mohamed Bouattour, Shi-Ming Lin, Jean-Marie Peron, Quang T Nguyen, Lünan Yan, Chang-Fang Chiu, Florinda A Santos, Anil Veluvolu, Satheesh Chiradoni Thungappa, Marco Matos, Magdalena Żotkiewicz, Stephanie I. Udoye, John F. Kurland, G. Cohen, Riccardo Lencioni, Kathia Cristina Abdalla, Manon Allaire, Gustavo R. Alves, Luís Carlos Moreira Antunes, Eric Assénat, Sérgio Jobim Azevedo, Rafael Barreto, Muhammad Shaalan Beg, Glaucio Bertollo, Jean‐Frédéric Blanc, Mohamed Bouattour, Rakesh Reddy Boya, Valery Breder, Jean–Pierre Bronowicki, Manoch Buranachokphaisan, Adam M. Burgoyne, Stephen L. Chan, Ting‐Tsung Chang, Yee Chao, Eric Chen, Xiaoming Chen, Chang-Fang Chiu, Minsig Choi, SUNGHEE CHOI, Natalie G. Coburn, Luis Contreras, Farshid Dayyani, Thomas Decaens, Arunee Dechaphunkul, Maria del Consuelo Diaz, Anouk Dev, Jamille Dutra, Melissa Eastgate, Jose Escobar, Bassam Estfan, Vittorio Ferrari, Anne-Claire Frin, Sandip Ganguly, Ranga Raman Ganta, Shanzhi Gu, Yabing Guo, Atsushi Hagihara, Jeong Heo, Chih‐Hung Hsu, Jimmy Hwang, Yoshitaka Inaba, Shikha Jain, D. Jonker, Shruti Kate, Shruti Kate, Naoya Kato, Tomokazu Kawaoka, Kwong‐Ming Kee, Seung Up Kim, Kiyohide Kioka, Hironori Koga, Masatoshi Kudo, Hidekatsu Kuroda, Phuong Uyen Le, Han-chu Lee, Joon Hyeok Lee, Teng-Yu Lee, Dongliang Li, Hailiang Li, Wei Li, Xiao Li, Cheng-Yao Lin, Shi-Ming Lin, Yamil Lopez
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Daniel S.W. Tan, Enriqueta Felip, Gilberto de Castro, Benjamin Solomon, Alastair Greystoke, Byoung Chul Cho, Manuel Cobo, Tae Min Kim, Sandip Ganguly, Enric Carcereny, Luis Paz‐Ares, Jaafar Bennouna, Marina Chiara Garassino, Michael Schenker, Sang‐We Kim, Jan C. Brase, Denise Bury-Maynard, Vanessa Q. Passos, Stéphanie Deudon, Bharani Dharan, Yuanbo Song, Rafael Caparica, Bruce E. Johnson
Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India
Joydeep Ghosh, Sandip Ganguly, Debapriya Mondal, Prashant Kumar Pandey, Deepak Dabkara, Bivas Biswas
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis
Santam Chakraborty, Sanjoy Chatterjee, Selvamani Backianathan, Punita Lal, Subhash C. Gupta, Rosina Ahmed, Shagun Misra, Patricia Solomon, Rajesh Balakrishan, Subecha Bhushal, Debashree Guha, Kishore Das, Anurupa Mahata, S. Mandal, Abha Kumari, Henry Finlay Godson, Sandip Ganguly, Abha Kumari, C. Shamsudden, M. Dinesh, Debdeep Dey